z-logo
Premium
Radiosynthesis and preliminary biological evaluation of a new 18 F‐labeled triethylene glycol derivative of triphenylphosphonium
Author(s) -
Tominaga Takahiro,
Ito Hiroaki,
Ishikawa Yoichi,
Iwata Ren,
Ishiwata Kiichi,
Furumoto Shozo
Publication year - 2016
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.3379
Subject(s) - chemistry , triethylene glycol , hydrobromide , biodistribution , bromide , radiosynthesis , radiochemistry , derivative (finance) , in vitro , nuclear chemistry , polymer chemistry , nuclear medicine , biochemistry , positron emission tomography , organic chemistry , medicine , economics , financial economics
Delocalized lipophilic cations such as [ 18 F]fluorobenzyltriphenylphosphonium ([ 18 F]FBnTP) can accumulate in mitochondria and have been used in myocardial perfusion imaging (MPI). In this study, we established a simplified method for [ 18 F]FBnTP synthesis using triphenylphosphine hydrobromide (PPh 3 •HBr) without preparing an intermediate that contains benzyl bromide structure. Applying this new method, we synthesized and evaluated a novel 18 F‐labeled PEGylated BnTP derivative ([ 18 F]FPEGBnTP). In vitro cellular uptake study demonstrated that [ 18 F]FPEGBnTP accumulated in cells in proportion to the relative intensity of mitochondrial membrane potential. Biodistribution study revealed that the heart : liver uptake ratio of [ 18 F]FPEGBnTP (4.00 at 60 min) was superior to that of [ 18 F]FBnTP (1.50 at 60 min). However, [ 18 F]FPEGBnTP showed slow blood clearance and high radioactivity uptake in bone at 120‐min post‐injection. These results imply the possibility of [ 18 F]FPEGBnTP being used as a MPI agent. However, there is a need of further structural optimization and flow‐dependent uptake study.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom